0000000001012133

AUTHOR

Lars T. Westlye

showing 2 related works from this author

What we learn about bipolar disorder from large-scale neuroimaging

2020

Abstract MRI‐derived brain measures offer a link between genes, the environment and behavior and have been widely studied in bipolar disorder (BD). However, many neuroimaging studies of BD have been underpowered, leading to varied results and uncertainty regarding effects. The Enhancing Neuro Imaging Genetics through Meta‐Analysis (ENIGMA) Bipolar Disorder Working Group was formed in 2012 to empower discoveries, generate consensus findings and inform future hypothesis‐driven studies of BD. Through this effort, over 150 researchers from 20 countries and 55 institutions pool data and resources to produce the largest neuroimaging studies of BD ever conducted. The ENIGMA Bipolar Disorder Workin…

mega-analysisStress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13]cortical surface areaReview Article0302 clinical medicineManic-depressive illnessMulticenter Studies as TopicSpectrum disorderReview Articlesbipolar disorderCerebral CortexTrastorn bipolarneuroimagingRadiological and Ultrasound Technology05 social sciencesENIGMAHUMAN BRAINMagnetic Resonance Imagingpsychiatry3. Good healthNeurologyMeta-analysisScale (social sciences)AnatomyPsychologyClinical risk factorClinical psychologyMRIMAJOR PSYCHIATRIC-DISORDERSSchizoaffective disorder050105 experimental psychology03 medical and health sciencesMagnetic resonance imagingNeuroimagingMeta-Analysis as TopicSDG 3 - Good Health and Well-beingImatges per ressonància magnèticamedicineHumans0501 psychology and cognitive sciencesRadiology Nuclear Medicine and imagingBipolar disorderHIPPOCAMPAL VOLUMESmega‐analysisGRAY-MATTER VOLUMESPECTRUM DISORDERvolumeDIABETES-MELLITUScortical thicknessCOGNITIVE IMPAIRMENTmedicine.diseaseMental illnessmeta-analysismeta‐analysisRC0321Neurology (clinical)SCHIZOAFFECTIVE DISORDERPSYCHOTIC FEATURES030217 neurology & neurosurgeryHuman Brain Mapping
researchProduct

Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative

2019

Abstract Background Lithium is recommended as a first line treatment for bipolar disorders. However, only 30% of patients show an optimal outcome and variability in lithium response and tolerability is poorly understood. It remains difficult for clinicians to reliably predict which patients will benefit without recourse to a lengthy treatment trial. Greater precision in the early identification of individuals who are likely to respond to lithium is a significant unmet clinical need. Structure The H2020-funded Response to Lithium Network (R-LiNK; http://www.r-link.eu.com/) will undertake a prospective cohort study of over 300 individuals with bipolar-I-disorder who have agreed to commence a …

medicine.medical_specialtyLithium (medication)[SDV]Life Sciences [q-bio]Psychological interventionOmicsNeuroimagingReviewLithiumDigitallcsh:RC321-57103 medical and health sciences0302 clinical medicinemedicineProspective cohort studyIntensive care medicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBiological PsychiatryPersonalizationbusiness.industrylcsh:QP351-495ResponseActigraphyPrecisionOmicsActigraphy3. Good health030227 psychiatryPsychiatry and Mental healthlcsh:Neurophysiology and neuropsychologyPhenotypeMoodTolerabilityBipolarBiomarker (medicine)business030217 neurology & neurosurgerymedicine.drugInternational Journal of Bipolar Disorders
researchProduct